PATENT CLAIM ANALYSIS

Application Number: 16092501
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "530000"]

Abstract:
Methods and compositions for reducing the risk of cardiovascular, cerebrovascular, or renovascular adverse events are provided. Generally, the methods include administering to a subject taking an NSAID a therapeutically effective amount of a misoprostol compound. The methods can also include administering to a subject in need thereof a therapeutically effective amount of an NSAID and therapeutically effective amount of a misoprostol compound.

Claim (Index 6):
The method of  claim 1 , wherein the NSAID is selected from an aceclofenac, a diclofenac, a difluinsal, a febufen, a flufenamic acid, an ibuprofen, an indomethacin, a ketoprofen, a meclofenamate sodium, a meloxicam, a mefenamic acid, a nabumetone, a naproxen, a piroxicam, a suprofen, a tiaprofenic acid, a flurbiprofen, a ketorolac, an oxaprozin, a sulindac, a valdecoxib, a celecoxib, a rofecoxib, a etoricoxib, and combinations thereof.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 97.0
- Lexical Diversity: 1.74359
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10790288', '11664604', '15144786', '10586381', '10586573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7551273803288406
- 35 USC 102 Novelty (BERT): 0.4999496356595748
- Combined Prediction Score: 0.729609605861914
- Mean Citation Score: 226.424842
- Max Citation Score: 246.4238
- Similarity Product: 181.9701693421125

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test